PL3058067T3 - Krążący biomarker nowotworowy i jego zastosowanie - Google Patents

Krążący biomarker nowotworowy i jego zastosowanie

Info

Publication number
PL3058067T3
PL3058067T3 PL14853838T PL14853838T PL3058067T3 PL 3058067 T3 PL3058067 T3 PL 3058067T3 PL 14853838 T PL14853838 T PL 14853838T PL 14853838 T PL14853838 T PL 14853838T PL 3058067 T3 PL3058067 T3 PL 3058067T3
Authority
PL
Poland
Prior art keywords
cancer biomarker
circulating cancer
circulating
biomarker
cancer
Prior art date
Application number
PL14853838T
Other languages
English (en)
Inventor
Pei-Jer Chen
Shiou-Hwei Yeh
Chiao-Ling LI
Ding-Shinn Chen
Original Assignee
National Taiwan University
Chung Wo, Andrew Man
Priority date (The priority date is an assumption and is not a legal conclusion. Google has not performed a legal analysis and makes no representation as to the accuracy of the date listed.)
Filing date
Publication date
Application filed by National Taiwan University, Chung Wo, Andrew Man filed Critical National Taiwan University
Publication of PL3058067T3 publication Critical patent/PL3058067T3/pl

Links

Classifications

    • C—CHEMISTRY; METALLURGY
    • C12—BIOCHEMISTRY; BEER; SPIRITS; WINE; VINEGAR; MICROBIOLOGY; ENZYMOLOGY; MUTATION OR GENETIC ENGINEERING
    • C12Q—MEASURING OR TESTING PROCESSES INVOLVING ENZYMES, NUCLEIC ACIDS OR MICROORGANISMS; COMPOSITIONS OR TEST PAPERS THEREFOR; PROCESSES OF PREPARING SUCH COMPOSITIONS; CONDITION-RESPONSIVE CONTROL IN MICROBIOLOGICAL OR ENZYMOLOGICAL PROCESSES
    • C12Q1/00—Measuring or testing processes involving enzymes, nucleic acids or microorganisms; Compositions therefor; Processes of preparing such compositions
    • C12Q1/68—Measuring or testing processes involving enzymes, nucleic acids or microorganisms; Compositions therefor; Processes of preparing such compositions involving nucleic acids
    • C12Q1/6876—Nucleic acid products used in the analysis of nucleic acids, e.g. primers or probes
    • C12Q1/6883—Nucleic acid products used in the analysis of nucleic acids, e.g. primers or probes for diseases caused by alterations of genetic material
    • C12Q1/6886—Nucleic acid products used in the analysis of nucleic acids, e.g. primers or probes for diseases caused by alterations of genetic material for cancer
    • C—CHEMISTRY; METALLURGY
    • C12—BIOCHEMISTRY; BEER; SPIRITS; WINE; VINEGAR; MICROBIOLOGY; ENZYMOLOGY; MUTATION OR GENETIC ENGINEERING
    • C12Q—MEASURING OR TESTING PROCESSES INVOLVING ENZYMES, NUCLEIC ACIDS OR MICROORGANISMS; COMPOSITIONS OR TEST PAPERS THEREFOR; PROCESSES OF PREPARING SUCH COMPOSITIONS; CONDITION-RESPONSIVE CONTROL IN MICROBIOLOGICAL OR ENZYMOLOGICAL PROCESSES
    • C12Q1/00—Measuring or testing processes involving enzymes, nucleic acids or microorganisms; Compositions therefor; Processes of preparing such compositions
    • C12Q1/70—Measuring or testing processes involving enzymes, nucleic acids or microorganisms; Compositions therefor; Processes of preparing such compositions involving virus or bacteriophage
    • C12Q1/701—Specific hybridization probes
    • C12Q1/706—Specific hybridization probes for hepatitis
    • C—CHEMISTRY; METALLURGY
    • C12—BIOCHEMISTRY; BEER; SPIRITS; WINE; VINEGAR; MICROBIOLOGY; ENZYMOLOGY; MUTATION OR GENETIC ENGINEERING
    • C12N—MICROORGANISMS OR ENZYMES; COMPOSITIONS THEREOF; PROPAGATING, PRESERVING, OR MAINTAINING MICROORGANISMS; MUTATION OR GENETIC ENGINEERING; CULTURE MEDIA
    • C12N2730/00—Reverse transcribing DNA viruses
    • C12N2730/00011—Details
    • C12N2730/10011—Hepadnaviridae
    • C12N2730/10111—Orthohepadnavirus, e.g. hepatitis B virus
    • C—CHEMISTRY; METALLURGY
    • C12—BIOCHEMISTRY; BEER; SPIRITS; WINE; VINEGAR; MICROBIOLOGY; ENZYMOLOGY; MUTATION OR GENETIC ENGINEERING
    • C12Q—MEASURING OR TESTING PROCESSES INVOLVING ENZYMES, NUCLEIC ACIDS OR MICROORGANISMS; COMPOSITIONS OR TEST PAPERS THEREFOR; PROCESSES OF PREPARING SUCH COMPOSITIONS; CONDITION-RESPONSIVE CONTROL IN MICROBIOLOGICAL OR ENZYMOLOGICAL PROCESSES
    • C12Q2600/00—Oligonucleotides characterized by their use
    • C12Q2600/112—Disease subtyping, staging or classification
    • C—CHEMISTRY; METALLURGY
    • C12—BIOCHEMISTRY; BEER; SPIRITS; WINE; VINEGAR; MICROBIOLOGY; ENZYMOLOGY; MUTATION OR GENETIC ENGINEERING
    • C12Q—MEASURING OR TESTING PROCESSES INVOLVING ENZYMES, NUCLEIC ACIDS OR MICROORGANISMS; COMPOSITIONS OR TEST PAPERS THEREFOR; PROCESSES OF PREPARING SUCH COMPOSITIONS; CONDITION-RESPONSIVE CONTROL IN MICROBIOLOGICAL OR ENZYMOLOGICAL PROCESSES
    • C12Q2600/00—Oligonucleotides characterized by their use
    • C12Q2600/156—Polymorphic or mutational markers

Landscapes

  • Chemical & Material Sciences (AREA)
  • Life Sciences & Earth Sciences (AREA)
  • Health & Medical Sciences (AREA)
  • Organic Chemistry (AREA)
  • Proteomics, Peptides & Aminoacids (AREA)
  • Zoology (AREA)
  • Immunology (AREA)
  • Wood Science & Technology (AREA)
  • Engineering & Computer Science (AREA)
  • Analytical Chemistry (AREA)
  • Genetics & Genomics (AREA)
  • Bioinformatics & Cheminformatics (AREA)
  • Pathology (AREA)
  • Molecular Biology (AREA)
  • Physics & Mathematics (AREA)
  • Biotechnology (AREA)
  • General Engineering & Computer Science (AREA)
  • Biochemistry (AREA)
  • Biophysics (AREA)
  • Microbiology (AREA)
  • General Health & Medical Sciences (AREA)
  • Communicable Diseases (AREA)
  • Hospice & Palliative Care (AREA)
  • Oncology (AREA)
  • Virology (AREA)
  • Measuring Or Testing Involving Enzymes Or Micro-Organisms (AREA)
  • Apparatus Associated With Microorganisms And Enzymes (AREA)
  • Micro-Organisms Or Cultivation Processes Thereof (AREA)
PL14853838T 2013-10-18 2014-10-17 Krążący biomarker nowotworowy i jego zastosowanie PL3058067T3 (pl)

Applications Claiming Priority (3)

Application Number Priority Date Filing Date Title
US201361892796P 2013-10-18 2013-10-18
EP14853838.2A EP3058067B1 (en) 2013-10-18 2014-10-17 Circulating cancer biomarker and its use
PCT/US2014/061127 WO2015058079A1 (en) 2013-10-18 2014-10-17 Circulating cancer biomarker and its use

Publications (1)

Publication Number Publication Date
PL3058067T3 true PL3058067T3 (pl) 2019-03-29

Family

ID=52828736

Family Applications (1)

Application Number Title Priority Date Filing Date
PL14853838T PL3058067T3 (pl) 2013-10-18 2014-10-17 Krążący biomarker nowotworowy i jego zastosowanie

Country Status (10)

Country Link
US (1) US20150119260A1 (pl)
EP (1) EP3058067B1 (pl)
JP (1) JP6309636B2 (pl)
KR (1) KR101955080B1 (pl)
CN (1) CN105874068B (pl)
ES (1) ES2687251T3 (pl)
PL (1) PL3058067T3 (pl)
SG (1) SG11201601234TA (pl)
TW (1) TWI573872B (pl)
WO (1) WO2015058079A1 (pl)

Families Citing this family (6)

* Cited by examiner, † Cited by third party
Publication number Priority date Publication date Assignee Title
EP3298169B1 (en) * 2015-05-18 2024-10-02 Karius, Inc. Compositions and methods for enriching populations of nucleic acids
TWI797095B (zh) * 2016-10-24 2023-04-01 美商格瑞爾有限責任公司 腫瘤檢測之方法及系統
WO2018137685A1 (en) 2017-01-25 2018-08-02 The Chinese University Of Hong Kong Diagnostic applications using nucleic acid fragments
WO2019020057A1 (en) 2017-07-26 2019-01-31 The Chinese University Of Hong Kong ENHANCING CANCER SCREENING WITH ACELLULAR VIRAL NUCLEIC ACIDS
GB201905244D0 (en) * 2019-04-12 2019-05-29 Ospedale San Raffaele Method for analysisng insertion sites
CA3237201A1 (en) 2021-11-16 2023-05-25 Sotio Biotech Inc. Treatment of myxoid/round cell liposarcoma patients

Family Cites Families (4)

* Cited by examiner, † Cited by third party
Publication number Priority date Publication date Assignee Title
US7078211B2 (en) * 2002-02-01 2006-07-18 Large Scale Biology Corporation Nucleic acid molecules encoding endonucleases and methods of use thereof
WO2012175013A1 (zh) * 2011-06-24 2012-12-27 深圳华大基因科技有限公司 用于确定人体具有异常状态的系统和方法
CN102839211A (zh) * 2011-06-24 2012-12-26 深圳华大基因科技有限公司 用于确定人体具有异常状态的系统和方法
WO2013075313A1 (zh) * 2011-11-24 2013-05-30 深圳华大基因科技有限公司 一种检测病毒在待测样本中整合方式的探针及其制备方法和应用

Also Published As

Publication number Publication date
EP3058067A4 (en) 2017-05-24
JP6309636B2 (ja) 2018-04-11
EP3058067B1 (en) 2018-08-01
EP3058067A1 (en) 2016-08-24
TW201525135A (zh) 2015-07-01
SG11201601234TA (en) 2016-03-30
KR101955080B1 (ko) 2019-03-06
US20150119260A1 (en) 2015-04-30
WO2015058079A1 (en) 2015-04-23
ES2687251T3 (es) 2018-10-24
CN105874068B (zh) 2020-04-10
CN105874068A (zh) 2016-08-17
KR20160055869A (ko) 2016-05-18
TWI573872B (zh) 2017-03-11
JP2016531596A (ja) 2016-10-13

Similar Documents

Publication Publication Date Title
IL244510A0 (en) Cancer biomarkers and their uses
IL246067A0 (en) Classification of prostate cancer
GB201322725D0 (en) Cancer therapy
SG10201801965RA (en) Treatment of cancer with dihydropyrazino-pyrazines
SG10201913730RA (en) Cancer therapy
ZA201507733B (en) Treatment of cancer with dihydropyrazino-pyrazines
GB201317149D0 (en) Ovulation Determination
PL2994148T3 (pl) Terapia nowotworowa
GB201322800D0 (en) Prostate cancer biomarkers
GB201316524D0 (en) Biomarkers
SG11201601234TA (en) Circulating cancer biomarker and its use
IL244632A0 (en) Cancer biomarker and diagnostic
GB201309426D0 (en) Biomarkers
EP2961412A4 (en) CANCER THERAPY
GB201316526D0 (en) Biomarkers
GB201307989D0 (en) Novel combinations and use
GB201308077D0 (en) Biomarkers
EP3015476A4 (en) Tumor biomarker
GB201312638D0 (en) Biomarkers
GB201304460D0 (en) Biomarker
GB201306394D0 (en) Cancer biomarker
GB201322783D0 (en) Biomarkers
GB201308259D0 (en) Cancer diagnosis and monitoring
GB201313342D0 (en) Biomarkers
TWM475709U (en) Antenna structure and its radiator